Rocket Lab Bolsters War Chest and European Ambitions with Key Deals

Rocket Lab shares surged 7% after a JMP upgrade to Outperform ($85 target) and completion of a capital program raising up to $1.1B for growth and the Mynaric acquisition.

Rocket Lab USA shares surged this week, propelled by a dual catalyst of fresh analyst optimism and the completion of a major capital program designed to fund its next strategic moves. The stock gained roughly 7% on Wednesday, closing near $70, as investors digested the news.

Citizens JMP upgraded the company's rating from "Market Perform" to "Outperform" on April 7, assigning an $85 price target. Analysts cited Rocket Lab's strong launch business, its growing defense segment, and an increasingly clear path toward higher-margin space services. They view the current valuation as an attractive entry point, forecasting "significant upside potential" over the next twelve months. The upgrade was followed by a notable afternoon rally, with the stock climbing 5.8% as broader risk assets recovered following a geopolitical development: a two-week ceasefire agreement between the US and Iran.

Financially, the company has solidified its foundation. It has fully completed an at-the-market (ATM) equity offering program, which was initiated in mid-March. The sale of approximately 6.73 million shares generated gross proceeds of about $474 million. Furthermore, Rocket Lab entered into collared forward transactions covering an additional 7.45 million shares. These instruments are expected to yield between $474 million and $642 million upon settlement in April 2028. In total, these efforts provide the company with between $948 million and $1.116 billion in available capital for growth investments, potential acquisitions, and general corporate purposes. This complements the $829 million in liquidity Rocket Lab reported holding at the end of 2025.

A primary destination for these funds is the pending acquisition of German laser communications specialist Mynaric AG. The deal, already approved by German authorities on March 30, carries a purchase price of $75 million, with an additional performance-based earnout of up to $75 million contingent on Mynaric's revenue performance between 2025 and 2027. Rocket Lab can settle the payment in cash or its own stock. The transaction is expected to close by the end of April 2026, establishing Mynaric's Munich headquarters as Rocket Lab's first European outpost, focused on high-speed data links for satellite constellations.

The company's growth narrative is supported by a substantial backlog. As of the end of the fourth quarter in 2025, its contracted order book stood at approximately $1.85 billion. This includes a $1.3 billion contract with the Space Development Agency for satellite manufacturing and an additional $190 million contract for hypersonics testing. For the upcoming quarterly report in May 2026, analysts anticipate revenue of around $191 million and a loss per share of $0.07. While the operating margin remains negative at -38%, the path to profitability is becoming clearer. Full-year revenue for 2025 reached $602 million, with projections for 2026 climbing to about $880 million. The Zacks consensus EPS estimate for 2026 has been revised upward by 44% over the past 60 days, with some projections pointing to potential profitability by early 2027.

Despite recent gains, the stock trades about 27% below its 52-week high of $96.30 reached in January. Its price-to-sales ratio on a trailing twelve-month basis is 40.7, significantly above the industry average of 11.7. A structural consideration for investors is the company's reliance on US government programs, which ties a material portion of its backlog to federal budget cycles and political decisions.